Evidence map›Paper›PMID 34236183›Full record

ArticleJournal of the American Chemical Society2021

Distinguishing Galactoside Isomers with Mass Spectrometry and Gas-Phase Infrared Spectroscopy.

Jordan S Ho, Amira Gharbi, Baptiste Schindler, Oznur Yeni, Richard Brédy, Laurent Legentil, Vincent Ferrières, Laura L Kiessling, Isabelle Compagnon

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Jordan S HoDepartment of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Avenue Cambridge, Massachusetts 02139, United States.ORCID 0000-0001-7355-0431
Amira GharbiUniv. Lyon, Université Claude Bernard Lyon 1, CNRS, Institut Lumière Matière, F-69622 Villeurbanne, France.
Baptiste SchindlerUniv. Lyon, Université Claude Bernard Lyon 1, CNRS, Institut Lumière Matière, F-69622 Villeurbanne, France.ORCID 0000-0002-7376-4154
Oznur YeniUniv. Lyon, Université Claude Bernard Lyon 1, CNRS, Institut Lumière Matière, F-69622 Villeurbanne, France.
Richard BrédyUniv. Lyon, Université Claude Bernard Lyon 1, CNRS, Institut Lumière Matière, F-69622 Villeurbanne, France.ORCID 0000-0003-0196-3477
Laurent LegentilUniv. Rennes, Ecole Nationale Supérieure de Chimie de Rennes, CNRS, UMR 6226 - ISCR, F-35000 Rennes, France.ORCID 0000-0003-1402-150X
Vincent FerrièresUniv. Rennes, Ecole Nationale Supérieure de Chimie de Rennes, CNRS, UMR 6226 - ISCR, F-35000 Rennes, France.ORCID 0000-0002-2780-7774
Laura L KiesslingDepartment of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Avenue Cambridge, Massachusetts 02139, United States.ORCID 0000-0001-6829-1500
Isabelle CompagnonUniv. Lyon, Université Claude Bernard Lyon 1, CNRS, Institut Lumière Matière, F-69622 Villeurbanne, France.ORCID 0000-0003-2994-3961
Université Claude Bernard Lyon 1 · FRCentre National de la Recherche Scientifique · FRMassachusetts Institute of Technology · US

Funding

The Chemistry and Biology of Galactofuranose-Containing GlycansR01AI126592 · NIAID · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Laura L Kiessling · 2017 to 2026
$5.2M
Chemoenzymatic synthesis of bacterial polysaccharidesU01GM125288 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KIESSLING, LAURA L, LI, LEI · 2017 to 2020
$3.1M
The Chemistry and Biology of Galactofuranose ResiduesR01AI063596 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI KIESSLING, LAURA L · 2005 to 2014
$3.0M
NIAID NIH HHS R01 AI063596NIAID NIH HHS R01 AI126592NIGMS NIH HHS U01 GM125288
6 · The paper itself

Abstract

Sequencing glycans is demanding due to their structural diversity. Compared to mammalian glycans, bacterial glycans pose a steeper challenge because they are constructed from a larger pool of monosaccharide building blocks, including pyranose and furanose isomers. Though mammalian glycans incorporate only the pyranose form of galactose (Gal

Indexed as

Carbohydrate ConformationGalactosidesKlebsiella pneumoniaeMass SpectrometryMycobacterium tuberculosisSpectrophotometry, InfraredStereoisomerismGalactosides

Identifiers

PMID34236183
PMCPMC9867933
OpenAlexW3180871499

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.